Published in Neurology on April 10, 2007
Driving and neurodegenerative diseases. Curr Neurol Neurosci Rep (2008) 1.15
Predicting road test performance in drivers with stroke. Am J Occup Ther (2014) 0.86
To drive or not to drive: roles of the physician, patient, and state. Neurology (2007) 0.75
Epileptic auras and their role in driving safety in people with epilepsy. Epilepsia (2015) 0.75
Current concepts in mild cognitive impairment. Arch Neurol (2001) 18.09
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology (2006) 12.10
Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol (1999) 10.45
Complete genome sequence and comparative analysis of the metabolically versatile Pseudomonas putida KT2440. Environ Microbiol (2002) 8.11
Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci (1996) 7.19
Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol (1998) 5.93
Fatal occupational injuries. JAMA (1982) 5.67
Fiber composition of the human corpus callosum. Brain Res (1992) 4.97
Inhibition of Trypanosoma brucei gene expression by RNA interference using an integratable vector with opposing T7 promoters. J Biol Chem (2000) 4.96
Cancer linked to Alzheimer disease but not vascular dementia. Neurology (2009) 4.83
Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science (1998) 4.07
Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol (2001) 3.80
Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 3.77
The AD8: a brief informant interview to detect dementia. Neurology (2005) 3.65
Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD. Neurology (2005) 3.55
Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology (2001) 3.30
Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology (1996) 3.23
Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly. Neuroimage (2005) 3.21
A longitudinal study of drivers with Alzheimer disease. Neurology (2008) 3.17
Functional brain imaging of young, nondemented, and demented older adults. J Cogn Neurosci (2000) 3.12
Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success? Int J Geriatr Psychiatry (2001) 3.09
A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group. Neurology (2000) 2.99
The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging (1992) 2.97
Protection against Alzheimer's disease with apoE epsilon 2. Lancet (1994) 2.96
Practice parameter update: evaluation and management of driving risk in dementia: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2010) 2.84
Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures. Neurology (1999) 2.61
Predictors of driving safety in early Alzheimer disease. Neurology (2009) 2.61
Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull (1988) 2.50
Reliability of the Washington University Clinical Dementia Rating. Arch Neurol (1988) 2.48
A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology (2001) 2.38
Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology (1995) 2.34
Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Dementia of the Alzheimer type. Neurology (2000) 2.31
A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Arch Neurol (1998) 2.22
Progressive posterior cortical dysfunction: a clinicopathologic series. Neurology (2004) 2.20
Motor and sensory cortex in humans: topography studied with chronic subdural stimulation. Neurosurgery (1992) 2.20
Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17
Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases. Neurology (1997) 2.13
The value of informant versus individual's complaints of memory impairment in early dementia. Neurology (2000) 2.10
Adrenal hemorrhage: a 25-year experience at the Mayo Clinic. Mayo Clin Proc (2001) 2.10
Isolation, characterization, and DNA sequence analysis of an AAC(6')-II gene from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1989) 2.08
Optimal use of blood tests for assessment of thyroid function. JAMA (1993) 2.00
Autosomal dominant dementia with widespread neurofibrillary tangles. Ann Neurol (1997) 1.98
Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study. Neurology (2004) 1.92
Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. J Neurophysiol (2001) 1.91
Polymerase chain reaction for detection of Toxoplasma gondii. J Med Microbiol (1990) 1.89
Effect of gastric acid suppressants on human gastric motility. Gut (1998) 1.89
PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology (2003) 1.86
Hereditary dysphasic disinhibition dementia: a frontotemporal dementia linked to 17q21-22. Neurology (1998) 1.85
CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology (2009) 1.85
Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana. Nature (2000) 1.85
Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease. Neurology (2011) 1.84
Reliability of the Washington University Road Test. A performance-based assessment for drivers with dementia of the Alzheimer type. Arch Neurol (1997) 1.84
Fatal unintentional carbon monoxide poisoning in motor vehicles. Am J Public Health (1972) 1.83
Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease. Neurology (2000) 1.82
Use of preoperative functional neuroimaging to predict language deficits from epilepsy surgery. Neurology (2003) 1.80
Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B. J Clin Oncol (1994) 1.77
Ischemic colitis during treatment with alosetron. Gastroenterology (2001) 1.74
Alpha-2 macroglobulin gene and Alzheimer disease. Nat Genet (1999) 1.73
Interlaboratory histopathologic assessment of Alzheimer neuropathology: different methodologies yield comparable diagnostic results. Alzheimer Dis Assoc Disord (1993) 1.72
Brief screening tests versus clinical staging in senile dementia of the Alzheimer type. J Am Geriatr Soc (1990) 1.69
Driving and epilepsy. A review and reappraisal. JAMA (1991) 1.69
Visual dysfunction in Parkinson disease without dementia. Neurology (2005) 1.67
Pyloric-sphincter dysfunction in patients with gastric ulcer. N Engl J Med (1973) 1.66
Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: a case-control study. Neurology (2010) 1.66
Scintigraphic evaluation of gastric emptying. Semin Nucl Med (1982) 1.65
Driver landmark and traffic sign identification in early Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.65
Road safety in drivers with Parkinson disease. Neurology (2009) 1.65
Microelectrode studies of the active Na transport pathway of frog skin. J Gen Physiol (1977) 1.64
A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat Genet (1998) 1.63
Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab (2005) 1.63
Cognitive profiles in dementia: Alzheimer disease vs healthy brain aging. Neurology (2008) 1.62
Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates. Antimicrob Agents Chemother (1991) 1.62
Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol (1988) 1.60
Alzheimer disease and cancer. Neurology (2005) 1.60
Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance. Neurology (1996) 1.59
Biphasic nature of gastric emptying. Gut (1988) 1.59
Esophageal scintigraphy to quantitate esophageal transit (quantitation of esophageal transit). Gastroenterology (1979) 1.59
Current concepts in the pathogenesis of Alzheimer's disease. Am J Med (1997) 1.58
Gastric emptying of a non-digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy. Neurogastroenterol Motil (2008) 1.58
Patient awareness of seizures. Neurology (1996) 1.56
Clinical characteristics and overall survival in genitourinary sarcomas treated with curative intent: a multicenter study. Eur Urol (2004) 1.56
American Academy of Neurology qualifications and guidelines for the physician expert witness. Neurology (2006) 1.54
Penile length is normal in most men seeking penile lengthening procedures. Int J Impot Res (2002) 1.53
The CERAD experience, Part VIII: Neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease. Neurology (1995) 1.51
Gastroesophageal (GE) scintiscanning to detect and quantitate GE reflux. Gastroenterology (1976) 1.50
Absence of cognitive impairment or decline in preclinical Alzheimer's disease. Neurology (2001) 1.50
Driving performance in persons with mild senile dementia of the Alzheimer type. J Am Geriatr Soc (1993) 1.50
Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. Cancer Res (2000) 1.49
Mild senile dementia of the Alzheimer type: 2. Longitudinal assessment. Ann Neurol (1988) 1.48
Characterization of murine Flt4 ligand/VEGF-C. Oncogene (1997) 1.46
Emergent EEG: indications and diagnostic yield. Neurology (2003) 1.45
In vivo sodium iodide symporter gene therapy of prostate cancer. Gene Ther (2001) 1.44
Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol (1999) 1.43
Cisapride accelerates colonic transit in constipated patients with colonic inertia. Am J Gastroenterol (1989) 1.42
Driving with distraction in Parkinson disease. Neurology (2006) 1.42
Reliability of clinical nurse specialists in the staging of dementia. Arch Neurol (1989) 1.41
Mapping the distribution of amobarbital sodium in the intracarotid Wada test by use of Tc-99m HMPAO with SPECT. Radiology (1991) 1.41
The hormonal regulation of pyloric sphincter function. J Clin Invest (1973) 1.40